BSEBacil Pharma LtdMediumNeutral
Announced Tue, 19 Aug · 14:20 IST

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 ,inter alia, to consider and approve 1. Discussion on Appointment of ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Bacil Pharma Ltd has informed BSE that its Board of Directors will meet on Monday, 25 August 2025. The key agenda items include considering the appointment of M/s Sarang Shivajirao Chavan & Associate as the new Statutory Auditor of the company and the appointment of a new Director. The meeting notice was signed by Ms. Chaitali Kalpataru Shah, Director & CFO. Any other business may also be taken up with the Chairperson's permission.

Likely market impact

The announcement signals upcoming changes in both the auditor and board composition. Shareholders should watch for the outcome of the 25 August meeting to understand whether these are routine end-of-term changes or replacements triggered by prior resignations.